NHS Framework - Blood Disorders including Haemophilia A and B - July 2024
Details
- Buyer
- NHS England
- Supplier(s)
- Value
- £31
- Topic
- Pharmaceutical products
- Published
- 11 June 2024
- Source
- uk:find_a_tender
Tender description
Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024<br/><br/>Offer reference number: CM/PHS/22/5661<br/><br/>Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 14 months.<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Lot 1: CM/PHS/22/5661/01 Standard Half-life Recombinant Factor VIII Standard Half-life Recombinant Factor VIII Lot 2: CM/PHS/22/5661/02 Enhanced Half-life Recombinant Factor VIII CM/PHS/22/5661/02 Enhanced Half-life Recombinant Factor VIII Lot 3: CM/PHS/22/5661/03 Emicizumab CM/PHS/22/5661/03 Emicizumab Lot 4: CM/PHS/22/5661/04 eftrenonacog alfa (rFIX EHL) CM/PHS/22/5661/04 eftrenonacog alfa (rFIX EHL) Lot 5: CM/PHS/22/5661/05 albutrepenonacog alfa (rFIX EHL) CM/PHS/22/5661/05 albutrepenonacog alfa (rFIX EHL) Lot 6: CM/PHS/22/5661/06 nonacog beta pegol (rFIX EHL) CM/PHS/22/5661/06 nonacog beta pegol (rFIX EHL) Lot 7: CM/PHS/22/5661/07 rFIX - Standard Half Life CM/PHS/22/5661/07 rFIX - Standard Half Life Lot 8: CM/PHS/22/5661/08 Recombinant Factor VII CM/PHS/22/5661/08 Recombinant Factor VII Lot 9: CM/PHS/22/5661/09 Porcine Factor VIII - susoctocog alfa CM/PHS/22/5661/09 Porcine Factor VIII - susoctocog alfa Lot 10: CM/PHS/22/5661/10 Factor VIII Inhibitor Bypassing Fraction CM/PHS/22/5661/10 Factor VIII Inhibitor Bypassing Fraction Lot 11: CM/PHS/22/5661/11 Factor IX - High Purity Factor IX CM/PHS/22/5661/11 Factor IX - High Purity Factor IX Lot 12: CM/PHS/22/5661/12 Factor X CM/PHS/22/5661/12 Factor X Lot 13: CM/PHS/22/5661/13 Factor XIII - Plasma Derived CM/PHS/22/5661/13 Factor XIII - Plasma Derived Lot 14: CM/PHS/22/5661/14 Factor XIII - Recombinant CM/PHS/22/5661/14 Factor XIII - Recombinant Lot 15: CM/PHS/22/5661/15 Von willebrands factor / Factor VIII CM/PHS/22/5661/15 Von willebrands factor / Factor VIII Lot 16: CM/PHS/22/5661/16 Von willebrands factor - Plasma Derived CM/PHS/22/5661/16 Von willebrands factor - Plasma Derived Lot 17: CM/PHS/22/5661/17 Von willebrands factor - Recombinant CM/PHS/22/5661/17 Von willebrands factor - Recombinant Lot 18: CM/PHS/22/5661/18 Fibrinogen Concentrate CM/PHS/22/5661/18 Fibrinogen Concentrate Lot 19: CM/PHS/22/5661/19 Prothrombin Complex dried CM/PHS/22/5661/19 Prothrombin Complex dried Lot 20: CM/PHS/22/5661/20 Protein C Concentrate CM/PHS/22/5661/20 Protein C Concentrate Lot 21: CM/PHS/22/5661/21 Fresh Frozen Plasma (all blood groups) CM/PHS/22/5561/21 Fresh Frozen Plasma (all blood groups) Lot 22: CM/PHS/22/5661/22 Freeze Dried Plasma CM/PHS/22/5661/22 Freeze Dried Plasma Lot 23: CM/PHS/22/5661/23 Caplacizumab CM/PHS/22/5661/23 Caplacizumab
Timeline
- Completed: Award date31 May 2024
- Completed: Award published11 June 2024Current notice
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Every tender is advertised on Atamis, the NHS's single eCommercial system, and larger contracts appear on Find a Tender. Much of this procurement flows through framework agreements and the Crown Commercial Service. Clinical services are commissioned directly or through the Provider Selection Regime. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
UK health spending has nearly quadrupled to £241.8bn in 2024/25, £20bn up on the year before. £140.6bn of that went to procurement, the biggest sector of UK public spending and the fastest-growing.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
14 similar open tenders
See more open tenders related to NHS Framework - Blood Disorders including Haemophilia A and B - July 2024.
- Open tender
Generic Drugs - Injections/Infusions
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
Related topics
Topics related to NHS Framework - Blood Disorders including Haemophilia A and B - July 2024, ranked by notice volume.
- 44,608£7.6tn
Related buyers
Buyers similar to NHS England.
- 509£245.0m
- 429£15.3bn
- 426£117.3m
- 380£641.6m
- 320£18.9bn
- 298£3.1bn
- 295£1.7bn
- 269£1.2bn
- 153£987.8m
- 147£115.2m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
